IGF-II promotes mesoderm formation

Developmental Biology

Volumn 227, Issue 1, 2000, Pages 133-145

  Morali, Olivier G ^a,b   Jouneau, Alice ^b   McLaughlin, K John ^c   Thiery, Jean Paul ^a   Larue, Lionel ^b  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c Department of Pathobiology School of Veterinary Medicine   (United States)

Author keywords

Cadherin; Cardiogenesis; ES cells; Gastrulation; IGF II; IGF1R; Imprinting; Mouse embryo; Myoge nesis; T brachyury

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GASTRULATION; GENOME IMPRINTING; IN VITRO STUDY; IN VIVO STUDY; MALE; MESODERM; MOUSE; NONHUMAN; PARTHENOGENESIS; PRIORITY JOURNAL; STEM CELL; TERATOMA;

ANIMALIA; MURINAE;

EID: 0034330935     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.2000.9875     Document Type: Article

References (68)

1. Activins are expressed in preimplantation mouse embryos and in ES and EC cells and are regulated on their differentiation
2. A functional analysis of imprinting in parthenogenetic embryonic stem cells
3. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis
4. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: A review
5. Role of insulin-like growth factors in embryonic and postnatal growth
6. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus
7. Genomic imprinting in mammals
8. An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo
9. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
10. Parthenogenetic activation of mouse oocytes in vitro with ethanol and benzyl alcohol
11. A growth-deficiency phenotype in heterozygous mice carrying an insulin- like growth factor II gene disrupted by targeting
12. Parental imprinting of the mouse insulin-like growth factor II gene
13. The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium
14. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice
15. Genetics of mouse growth
16. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes
17. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: Greater mitogenic actions of IGF-I delay differentiation
18. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression
19. 'Spontaneous' differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II
20. Expression of a type I insulin-like growth factor receptor with low affinity for insulin-like growth factor II
21. A new 185,000-dalton skeletal muscle protein detected by monoclonal antibodies
22. In situ hybridization: An improved whole-mount method for Xenopus embryos
23. Patterning the Xenopus blastula
24. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development
25. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
26. Two examples of monoamniotic monozygotic twinning in diploid parthenogenetic mouse embryos
27. Hematopoietic commitment during embryonic stem cell differentiation in culture
28. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts
29. A role for cadherins in tissue formation
30. Igf2r and Igf2 gene expression in androgenetic, gynogenetic, and parthenogenetic preimplantation mouse embryos: Absence of regulation by genomic imprinting
31. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality
32. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis
33. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
34. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
35. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds
36. Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: Implications for genetic imprinting
37. Teratocarcinomas as a model system for the study of embryogenesis and neoplasia
38. Functional analysis of activins during mammalian development
39. Induction of the prospective neural crest of Xenopus
40. Nuclear transplantation in mouse embryos
41. Inability of mouse blastomere nuclei transferred to enucleated zygotes to support development in vitro
42. Myogenesis in cultures of uniparental mouse embryonic stem cells: Differing patterns of expression of myogenic regulatory factors
43. Roles of the imprinted gene Igf2 and paternal duplication of distal chromosome 7 in the perinatal abnormalities of androgenetic mouse chimeras
44. In vitro chamber specification during embryonic stem cell cardiogenesis. Expression of the ventricular myosin light chain-2 gene is independent of heart tube formation
45. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage
46. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells
47. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4
48. Binding of insulin-like growth factor II (IGF-II) by human cation-independent mannose 6-phosphate receptor/IGF-II receptor expressed in receptor-deficient mouse L cells
49. 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process
50. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2
51. IGF-I is required for normal embryonic growth in mice
52. The in vitro cultivation and differentiation capacities of myogenic cell lines
53. M-twist expression inhibits mouse embryonic stem cell-derived myogenic differentiation in vitro
54. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: Developmentally regulated expression of myogenic determination genes and functional expression of ionic currents
55. MesP1: A novel basic helix-loop-helix protein expressed in the nascent mesodermal cells during mouse gastrulation
56. The mouse Gt12 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA
57. Xenopus axis formation: Induction of goosecoid by injected Xwnt-8 and activin mRNAs
58. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts
59. Expression and methylation of imprinted genes during in vitro differentiation of mouse parthenogenetic and androgenetic embryonic stem cell lines
60. Allele-specific expression and total expression levels of imprinted genes during early mouse development: Implications for imprinting mechanisms
61. Mouse gastrulation: The formation of a mammalian body plan
62. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: Evidence for chamber-specific molecular determinants of conduction
63. The IGF system during fetal-placental development of the mouse
64. Myogenin is required for late but not early aspects of myogenesis during mouse development
65. Rabbit antiserum against a purified surface glycoprotein decompacts mouse preimplantation embryos and reacts with specific adult tissues
66. Retention of differentiation potentialities during prolonged cultivation of myogenic cells
67. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle